ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

INVA Innoviva Inc

14,93
0,00 (0,00%)
23 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Innoviva Inc INVA NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 14,93 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
14,93
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
08.3.202401:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.3.202400:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202423:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29.2.202422:15EDGAR2Form 8-K - Current report
29.2.202422:05BWInnoviva Reports Fourth Quarter and Full Year 2023 Financial..
23.2.202403:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.2.202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202413:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23.1.202403:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.1.202402:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
17.11.202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.11.202314:30EDGAR2Form 8-K - Current report
01.11.202321:30EDGAR2Form 8-K - Current report
01.11.202321:15BWInnoviva Reports Third Quarter 2023 Financial Results and..
01.11.202321:05BWPositive Results Announced in Largest Pivotal Phase 3 Trial..
19.9.202314:30BWInnoviva to Participate in the Cantor Global Healthcare..
18.9.202314:00BWXACDURO®, The First and Only Antibiotic Developed to Target..
01.9.202302:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31.8.202319:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25.8.202323:24EDGAR2Form 8-K - Current report
25.8.202322:52BWInnoviva Appoints Stephen Basso as Chief Financial Officer
07.8.202322:42EDGAR2Form 8-K - Current report
03.8.202303:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.8.202322:15EDGAR2Form 8-K - Current report
02.8.202322:05BWInnoviva Reports Second Quarter 2023 Financial Results and..
11.7.202314:16EDGAR2Form 8-K - Current report
06.6.202322:05BWInnoviva to Participate in the Goldman Sachs Annual Global..
24.5.202301:10DJNFDA Approves Innoviva's Bacterial Pneumonia Treatment
24.5.202300:42BWInnoviva Specialty Therapeutics Announces FDA Approval for..
12.5.202300:45BWResults from Pivotal Phase 3 ATTACK Trial of Investigational..
09.5.202322:32BWInnoviva Reports First Quarter 2023 Financial Results and..
28.4.202323:30BWInnoviva Announces Retirement of Board Chairman

Kürzlich von Ihnen besucht

Delayed Upgrade Clock